Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach

被引:17
|
作者
Matsufuji, Tetsuyoshi [1 ]
Shimada, Kousei [1 ]
Kobayashi, Shozo [1 ]
Ichikawa, Masanori [1 ]
Kawamura, Asuka [1 ]
Fujimoto, Teppei [1 ]
Arita, Tsuyoshi [1 ]
Hara, Takashi [2 ]
Konishi, Masahiro [2 ]
Abe-Ohya, Rie [2 ]
Izumi, Masanori [2 ]
Sogawa, Yoshitaka [2 ]
Nagai, Yoko [3 ]
Yoshida, Kazuhiro [3 ]
Abe, Yasuyuki [4 ]
Kimura, Takako [5 ]
Takahashi, Hisashi [1 ]
机构
[1] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[4] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan
[5] Daiichi Sankyo RD NOVARE Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan
关键词
Anti-obesity; Antedrug; Bombesin receptor subtype-3 (BRS-3); Brain penetration; Diazepine; TERT-BUTANESULFINYL IMINES; ASYMMETRIC-SYNTHESIS; BODY-TEMPERATURE; NERVOUS-SYSTEM; OBESE SUBJECTS; WEIGHT-LOSS; DISCOVERY; OVERWEIGHT; AMINES; SIBUTRAMINE;
D O I
10.1016/j.bmc.2014.11.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel compounds based on the lead BRS-3 agonists from our HTS compounds 2a and 2b have been synthesized with the focus on obtaining peripheral BRS-3 agonists. To identify potent anti-obesity compounds without adverse effects on the central nerve system, a labile carboxylic ester with an antedrug functionality was introduced onto the terminal position. Through the extensive synthetic exploration and the pharmacokinetic studies of oral administration in mice, the phenol ester 17c was selected due to the most suitable pharmacological profile. In the evaluation of food intake suppression in B6 mice, 17c showed significant in vivo efficacy and no clear adverse effect on heart rate and blood pressure change in dog iv infusion. Our study paved the way for development of anti-diabetes and obesity drugs with a safer profile. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 104
页数:16
相关论文
共 50 条
  • [41] Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor
    Wang, Zunyuan
    Yang, Yewei
    Zheng, Xiaoliang
    Zhang, Tao
    Huang, Wenhai
    Yan, Dongmei
    Zhang, Wenjun
    Wang, Xiaoju
    Shen, Zhengrong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (07) : 910 - 918
  • [42] Design, synthesis and biological evaluation of novel tetrahydroisoquinoline quaternary derivatives as peripheral κ-opioid receptor agonists
    Guo, Ting
    Gan, Zongjie
    Chen, Jie
    Wang, Dechuan
    He, Ling
    Song, Qiao
    Xu, Yungen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (13) : 2964 - 2970
  • [43] Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel μ opioid receptor ligands
    Allen, MP
    Blake, JF
    Bryce, DK
    Haggan, ME
    Liras, S
    McLean, S
    Segelstein, BE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (06) : 523 - 526
  • [44] Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists
    Maruyama, Tatsuya
    Onda, Kenichi
    Hayakawa, Masahiko
    Seki, Norio
    Takahashi, Takumi
    Moritomo, Hiroyuki
    Suzuki, Takayuki
    Matsui, Tetsuo
    Takasu, Toshiyuki
    Nagase, Itsuro
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (09) : 3283 - 3294
  • [45] Synthesis and Evaluation of Novel Phenylethanolamine Derivatives containing Acetanilides as Potent and Selective β3-Adrenergic Receptor Agonists
    Maruyama, Tatsuya
    Onda, Kenichi
    Hayakawa, Masahiko
    Suzuki, Takayuki
    Kimizuka, Tetsuya
    Matsui, Tetsuo
    Takasu, Toshiyuki
    Nagase, Itsuro
    Hamada, Noritaka
    Ohta, Mitsuaki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (04) : 533 - 545
  • [46] Synthesis and biological evaluation of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists
    Wang, Xuekun
    Zhao, Tianxiao
    Yang, Baowei
    Li, Zheng
    Cui, Jian
    Dai, Yuxuan
    Qiu, Qianqian
    Qiang, Hao
    Huang, Wenlong
    Qian, Hai
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 132 - 140
  • [47] Design, synthesis, and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel μ opioid receptor ligands.
    Allen, MP
    Blake, JF
    Bryce, DK
    Haggan, ME
    Liras, S
    McLean, S
    Segelstein, BE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U49 - U49
  • [48] Design, Synthesis, and Evaluation of Novel 3,6-Diaryl-4-aminoalkoxyquinolines as Selective Agonists of Somatostatin Receptor Subtype 2
    Wolkenberg, Scott E.
    Zhao, Zhijian
    Thut, Catherine
    Maxwell, Jill W.
    McDonald, Terrence P.
    Kinose, Fumi
    Reilly, Michael
    Lindsley, Craig W.
    Hartman, George D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2351 - 2358
  • [49] Synthesis and biological evaluation of 2,3′-diindolylmethanes as agonists of aryl hydrocarbon receptor
    Winston-McPherson, Gabrielle N.
    Shu, Dongxu
    Tang, Weiping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 4023 - 4025
  • [50] Synthesis and biological evaluation of novel vitamin D3 derivatives
    Li, Wei
    Zmijewski, Michal A.
    Chen, Jianjun
    Janjetovic, Zorica
    Zjawiony, Jordan K.
    Sweatman, Trevor
    Miller, Duane D.
    Slominski, Andrzej T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237